The Ministry of Science and Technology as well as other governmental bodies in China are considering the implementation of a tax break or exemption for companies that invest in new drug development. Up to this time, China has not been a major... Read More
South Korea’s Ministry of Finance and Economy recently announced their plans to develop five Special Economic Zones (SEZs) throughout the country. The plan is part of the Korean government’s endeavor to attract greater foreign investments into the country. Besides special tax incentives... Read More
In an effort to strengthen Japan’s drug development capabilities, a group of about 20 public, academic, and private organizations are together forming the Kansai Bio-Information Highway Project. The project comprises of an extensive computer-networking endeavor that will allow participants of the project... Read More
Slowing economies have not stopped Asian countries from moving ahead with medical device regulatory reforms. Asian consumers demand high-quality healthcare products, making it worthwhile for American manufactures to be active in the region. Procedures and practices vary according to country. This article... Read More
Controversy has arisen between US drug manufacturers and the Korean government regarding the reform of South Korea’s national health insurance system and its affects on drug pricing. Proposals have been made by Korea’s Health Ministry to implement a new reference pricing system... Read More
The Japanese House of Representatives passed and enacted the revised Pharmaceutical Affairs Law on July 25, 2002. The revision of the law will facilitate start-up pharmaceutical and medical device companies that do not have production facilities in Japan to enter into the... Read More
The Singapore government has set aside another S$25 million (US$14.3 million) to distribute to promising companies in the life-sciences industry. Singapore’s Economic Development Board has already spent in excess of S$150 million (US$86 million) in 50 portfolio companies. The money will come... Read More
Scientists in Singapore will be allowed to withdraw stem cells from adult human tissues, aborted fetuses, and surplus embryos less than 14 years old for research purposes, according to new guidelines approved by the Central Government July 17, 2002. The cloning of... Read More
In recent years, the demand for natural products and supplements has skyrocketed worldwide, fuelled by increasing acceptance of traditional herbal medicines and popular consumer demand for alternative therapies. The Asian markets are a major part of this trend. With a strong history... Read More
A recent report by the accounting firm, Ernst & Young, finds an increase in the amount of investment by governments in the Asia-Pacific region in biotechnology. Besides investment incentives and tax breaks, governments have begun to nurture the fledgling industry with increased... Read More